Colgate-Palmolive (NYSE:CL) Shares Sold by Swiss National Bank

Swiss National Bank decreased its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 5.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,192,800 shares of the company’s stock after selling 121,600 shares during the quarter. Swiss National Bank owned approximately 0.27% of Colgate-Palmolive worth $199,347,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Chicago Partners Investment Group LLC raised its stake in Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares in the last quarter. Peak Financial Advisors LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $1,315,000. Fiduciary Alliance LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $4,066,000. Impact Partnership Wealth LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $803,000. Finally, Barclays PLC raised its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the topic of a number of research reports. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. Finally, Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $101.61.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $90.41 on Friday. The stock has a fifty day moving average price of $89.03 and a two-hundred day moving average price of $94.93. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm has a market cap of $73.37 billion, a P/E ratio of 25.69, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company posted $0.87 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.